BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 15252397)

  • 1. [Role of CT/111In-octreotide SPECT digital fusion imaging in the localization of loco-regional recurrence of medullary thyroid carcinoma].
    Fiore D; Rubello D; Casara D; Pelizzo MR; Franchi A; Muzzio PC
    Minerva Chir; 2004 Jun; 59(3):295-9. PubMed ID: 15252397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The contribution of somatostatin receptor scintigraphy to the diagnosis of recurrent medullary carcinoma of the thyroid.
    Dörr U; Sautter-Bihl ML; Bihl H
    Semin Oncol; 1994 Oct; 21(5 Suppl 13):42-5. PubMed ID: 7992080
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of In-111 octreotide and Tc-99m (V) DMSA scintigraphy in the detection of medullary thyroid tumor foci in patients with elevated levels of tumor markers after surgery.
    Arslan N; Ilgan S; Yuksel D; Serdengecti M; Bulakbasi N; Ugur O; Ozguven MA
    Clin Nucl Med; 2001 Aug; 26(8):683-8. PubMed ID: 11452174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatostatin receptor scintigraphy for early detection of regional and distant metastases of medullary carcinoma of the thyroid.
    Krausz Y; Rosler A; Guttmann H; Ish-Shalom S; Shibley N; Chisin R; Glaser B
    Clin Nucl Med; 1999 Apr; 24(4):256-60. PubMed ID: 10466522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 111In-pentetreotide scintigraphy in the post-thyroidectomy follow-up of patients with medullary thyroid carcinoma.
    Celentano L; Sullo P; Klain M; Lupoli G; Cascone E; Salvatore M
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):131-3. PubMed ID: 9002771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 111In-octreotide scintigraphy in metastatic medullary thyroid carcinoma before and after octreotide therapy: in vivo evidence of the possible down-regulation of somatostatin receptors.
    Ronga G; Salerno G; Procaccini E; Mauro L; Annovazzi A; Barone R; Mellozzi M; Tamburrano G; Signore A
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):134-6. PubMed ID: 9002772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indium-111-DTPA-D-Phe-1-octreotide and technetium-99m-(V)-dimercaptosuccinic acid scanning in the preoperative staging of medullary thyroid carcinoma.
    Kurtaran A; Scheuba C; Kaserer K; Schima W; Czerny C; Angelberger P; Niederle B; Virgolini I
    J Nucl Med; 1998 Nov; 39(11):1907-9. PubMed ID: 9829581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of 18F-FDG PET/CT in detecting metastatic deposits of recurrent medullary thyroid carcinoma: a prospective study.
    Rubello D; Rampin L; Nanni C; Banti E; Ferdeghini M; Fanti S; Al-Nahhas A; Gross MD
    Eur J Surg Oncol; 2008 May; 34(5):581-6. PubMed ID: 17892923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The scintigraphy of somatostatin receptors in the carcinoid tumor].
    Banzo J; Abós MD; Prats E; Delgado M; Razola P; García S; Gomollón F; García F
    Rev Esp Med Nucl; 2001 Feb; 20(1):11-8. PubMed ID: 11181324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 111In-octreotide and 99mTc(V)-dimercaptosuccinic acid studies in the imaging of recurrent medullary thyroid carcinoma.
    Berná L; Cabezas R; Mora J; Torres G; Estorch M; Carrió I
    J Endocrinol; 1995 Feb; 144(2):339-45. PubMed ID: 7706986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of somatostatin analogue scintigraphy in the localization of recurrent medullary thyroid carcinoma.
    Bernà L; Chico A; Matías-Guiu X; Mato E; Catafau A; Alonso C; Mora J; Mauricio D; Rodríguez-Espinosa J; Marí C; Flotats A; Martín JC; Estorch M; Carrió I
    Eur J Nucl Med; 1998 Nov; 25(11):1482-8. PubMed ID: 9799343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical strategy for the treatment of sporadic medullary thyroid carcinoma: our experience.
    Lupone G; Antonino A; Rosato A; Zenone P; Iervolino EM; Grillo M; De Palma M
    G Chir; 2012; 33(11-12):395-9. PubMed ID: 23140924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential role of fluorine-18-deoxyglucose (FDG) positron emission tomography (PET) in the staging of primitive and recurrent medullary thyroid carcinoma.
    Gasparoni P; Rubello D; Ferlin G
    J Endocrinol Invest; 1997 Oct; 20(9):527-30. PubMed ID: 9413806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thoracic and abdominal SPECT-CT image fusion without external markers in endocrine carcinomas. The Group of Thyroid Tumoral Pathology of Champagne-Ardenne.
    Pérault C; Schvartz C; Wampach H; Liehn JC; Delisle MJ
    J Nucl Med; 1997 Aug; 38(8):1234-42. PubMed ID: 9255157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined use of 111In-DTPA-D-Phe-1-octreotide (OCT) and 123I-vasoactive intestinal peptide (VIP) in the localization diagnosis of medullary thyroid carcinoma (MTC).
    Kurtaran A; Leimer M; Kaserer K; Yang Q; Angelberger P; Niederle B; Virgolini I
    Nucl Med Biol; 1996 May; 23(4):503-7. PubMed ID: 8832707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatostatin analogs in the treatment of medullary thyroid carcinoma.
    Díez JJ; Iglesias P
    J Endocrinol Invest; 2002 Oct; 25(9):773-8. PubMed ID: 12398235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of octreotide scintigraphy and conventional imaging in medullary thyroid carcinoma.
    Baudin E; Lumbroso J; Schlumberger M; Leclere J; Giammarile F; Gardet P; Roche A; Travagli JP; Parmentier C
    J Nucl Med; 1996 Jun; 37(6):912-6. PubMed ID: 8683310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraoperative localization of recurrent medullary carcinoma of the thyroid using indium-111 pentetreotide and a nuclear surgical probe.
    Waddington WA; Kettle AG; Heddle RM; Coakley AJ
    Eur J Nucl Med; 1994 Apr; 21(4):363-4. PubMed ID: 7911761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatostatin-receptor scintigraphy for staging and follow-up of patients with extraintestinal marginal zone B-cell lymphoma of the mucosa associated lymphoid tissue (MALT)-type.
    Raderer M; Traub T; Formanek M; Virgolini I; Osterreicher C; Fiebiger W; Penz M; Jäger U; Pont J; Chott A; Kurtaran A
    Br J Cancer; 2001 Nov; 85(10):1462-6. PubMed ID: 11720429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Recidived medullary thyroid carcinoma with neck metastases and tracheal invasion].
    Pino Rivero V; González Palomino A; Trinidad Ruíz G; Marcos García M; Keituqwa Yáñez T; Carrasco Claver F; Blasco Huelva A
    An Otorrinolaringol Ibero Am; 2005; 32(5):445-52. PubMed ID: 16318087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.